B6.Cg-Tg(PECAM1-TFPI/CD4/SELP)#aAdor/AdorH
Status | Available to order |
EMMA ID | EM:08452 |
Citation information | RRID:IMSR_EM:08452 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | B6.Cg-Tg(PECAM1-TFPI/CD4/SELP)#aAdor/AdorH |
Alternative name | CD31-TFPI-Tg (also known as XCON6) |
Strain type | Transgenic Strains |
Allele/Transgene symbol | Tg(PECAM1-TFPI/CD4/SELP)#aAdor |
Gene/Transgene symbol | Tg(PECAM1-TFPI/CD4/SELP)#aAdor |
Information from provider
Provider | Anthony Dorling |
Provider affiliation | Innate Immunity, King's College London |
Additional owner | Mark Thursz, Imperial College London, UK and Li Ke, Xi'an Jiatong University, China |
Genetic information | Human tissue factor pathway inhibitor/CD4/P-selectin construct, with a modified CD31 promoter, introduced by microinjection. Copy number originally >30. |
Phenotypic information | Homozygous:Mice express membrane tethered human TFPI-CD4 fusion protein on all CD31+ cells, which includes endothelial cells, monocytes and platelets. In all these, it is internalised within secretory granules at resting state by virtue of P-selectin cytoplasmic sequence. The fusion protein appears on the membrane on activation. The hTFPI inhibits tissue factor and FXa.Heterozygous:Exactly as homozygous. |
Breeding history | Started backcrossing onto C57BL/6 in 2003, and then bred as sibling pairs since 2009. |
References |
|
Homozygous fertile | yes |
Homozygous viable | yes |
Homozygous matings required | no |
Immunocompromised | no |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Literature references
- Human tissue factor pathway inhibitor fused to CD4 binds both FXa and TF/FVIIa at the cell surface.;Riesbeck K, Dorling A, Kemball-Cook G, McVey J H, Jones M, Tuddenham E G, Lechler R I, ;1997;Thrombosis and haemostasis;78;1488-94; 9423800
- Inhibition of tissue factor-dependent and -independent coagulation by cell surface expression of novel anticoagulant fusion proteins.;Chen D, Riesbeck K, Kemball-Cook G, McVey J H, Tuddenham E G, Lechler R I, Dorling A, ;1999;Transplantation;67;467-74; 10030296
- Regulated inhibition of coagulation by porcine endothelial cells expressing P-selectin-tagged hirudin and tissue factor pathway inhibitor fusion proteins.;Chen D, Riesbeck K, McVey J H, Kemball-Cook G, Tuddenham E G, Lechler R I, Dorling A, ;1999;Transplantation;68;832-9; 10515384
- Human thrombin and FXa mediate porcine endothelial cell activation; modulation by expression of TFPI-CD4 and hirudin-CD4 fusion proteins.;Chen D, Riesbeck K, McVey J H, Kemball-Cook G, Tuddenham E G, Lechler R I, Dorling A, ;2001;Xenotransplantation;8;258-65; 11737851
- Inhibition of intravascular thrombosis in murine endotoxemia by targeted expression of hirudin and tissue factor pathway inhibitor analogs to activated endothelium.;Chen Daxin, Giannopoulos Konstantinos, Shiels Paul G, Webster Zoe, McVey John H, Kemball-Cook Geoff, Tuddenham Edward, Moore Marilyn, Lechler Robert, Dorling Anthony, ;2004;Blood;104;1344-9; 15126322
- Complete inhibition of acute humoral rejection using regulated expression of membrane-tethered anticoagulants on xenograft endothelium.;Chen Daxin, Weber Michele, McVey John H, Kemball-Cook Geoffrey, Tuddenham Edward G D, Lechler Robert I, Dorling Anthony, ;2004;American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons;4;1958-63; 15575897
- NK-cell-dependent acute xenograft rejection in the mouse heart-to-rat model.;Chen Daxin, Weber Michele, Lechler Robert, Dorling Anthony, ;2006;Xenotransplantation;13;408-14; 16925664
- Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1-dependent leukocyte recruitment in vivo.;Chen Daxin, Carpenter Adam, Abrahams Joel, Chambers Rachel C, Lechler Robert I, McVey John H, Dorling Anthony, ;2008;The Journal of experimental medicine;205;1739-46; 18606855
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).